New Research Finds Asthma Drug Very Promising In Treating Alzheimer’s Disease
Excerpt from the article:
“A laboratory study determined that asthma drug salbutamol can help prevent the formation of proteins associated with Alzheimer’s disease. Since this was still a lab study, scientists wanted to take the next step of testing the drug in animal models.
Brains of those suffering from Alzheimer’s disease show plaques between the nerve cells. Clumps of fibers called neurofibrillary tangles are also present inside the cells. These plaques consist of the beta-amyloid protein, while the tangles are made up of tau. During clinical trials, researchers found out that drugs that clear the beta-amyloid protein did not slow down the progression of the disease. As a result, they shifted their attention to tau.”
Click the button below to read the article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?